[Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast].
Schmid
K W
KW
Pathologisches Institut, Universität Innsbruck.
Hittmair
A
A
Tötsch
M
M
Müller
E
E
Zaimet
A
A
Tauscher
T
T
Dünser
M
M
Ofner
D
D
D000230:Adenocarcinoma / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000032:analysis*; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008668:Metallothionein / Q000032:analysis*; D010051:Ovarian Neoplasms / Q000473:pathology*; D010053:Ovary / Q000473:pathology*; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D014594:Uterine Neoplasms / Q000473:pathology*; D014599:Uterus / Q000473:pathology*
D014408:Biomarkers, Tumor; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D008668:Metallothionein
Metallothionein-Expression in normalen Endometrium und Karzinomen des Uterus, des Ovars und der Mamma.